1-Palmitoyl-2-oleoyl-sn-glycero-3-(phospho-rac-(1-glycerol)) Completed Phase 2 Trials for Hypoxemic Acute Respiratory Failure Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00578734Lucinactant for Treatment of Acute Hypoxemic Respiratory Failure in Children up to Two Years Old